ARTICLE | Clinical News
CentoRx update
May 9, 1994 7:00 AM UTC
CNTO provided a clinical progress update in its quarterly conference call.
The 1,400-patient European Capture trial of CentoRx gpIIb/IIIa inhibitor for unstable angina, renamed ReoPro, is accruing patients and is slated to end in late 1994 or early 1995. The 2,100-patient ReoPro trial for restenosis is scheduled to end in the fourth quarter of 1995. ...